Case report<br>Omalizumab as a new therapeutic approach for children with severe asthma

Joanna Jerzyńska; Anna Sztafińska; Katarzyna Woicka-Kolejwa; Iwona Stelmach

doi:10.5114/pdia.2014.40660

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2014
vol. 31

Send email

Copy url:

abstract:

Case report
Omalizumab as a new therapeutic approach for children with severe asthma

Joanna Jerzyńska

,

Anna Sztafińska

,

Katarzyna Woicka-Kolejwa

,

Iwona Stelmach

Postep Derm Alergol 2014; XXXI, 1: 45–46

DOI: https://doi.org/10.5114/pdia.2014.40660

Online publish date: 2014/02/25

View full text Get citation

Omalizumab has been shown to improve asthma control when added to a regimen of guideline-based therapy for inner-city children and adolescents, nearly eliminating seasonal peaks in exacerbation and reducing the need for other medications to control asthma. Below, we describe a case of a 17-year-old non-smoker with a history of severe asthma admitted to our clinic after unsuccessful 10-year immunotherapy. The patient fulfilled the criteria for anti-IgE therapy, he was prescribed omalizumab 600 mg every 2 weeks. During therapy he was able to reduce his use of ICS and did not require any oral corticosteroids. He experienced an increase in his ability to exercise and noted no exacerbation of asthma symptoms. It is possible that in our patient, specific immunotherapy could be successfully continued after the initiation of omalizumab therapy.

keywords:

Case reportOmalizumab as a new therapeutic approach for children with severe asthma

Joanna Jerzyńska , Anna Sztafińska , Katarzyna Woicka-Kolejwa , Iwona Stelmach

omalizumab, severe asthma, immunotherapy

Case report
Omalizumab as a new therapeutic approach for children with severe asthma

Joanna Jerzyńska

,

Anna Sztafińska

,

Katarzyna Woicka-Kolejwa

,

Iwona Stelmach